Full text is available at the source.
Abstract
Swimming nanorobots show great potential in active targeted delivery of drugs for glioblastoma multiforme (GBM).
- GBM is characterized by significant morbidity and mortality, making effective treatment challenging.
- The blood-brain barrier and blood-brain tumor barrier hinder drug uptake by GBM, limiting therapeutic options.
- Recent advancements in nanotechnology offer unconventional drug delivery approaches for GBM treatment.
- Nanorobots can navigate biological barriers more effectively, enhancing targeted drug delivery strategies.
- Current challenges in translating these technologies into clinical practice are acknowledged.
Simplified